Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$51.39 - $66.9 $7.62 Million - $9.92 Million
-148,300 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$49.14 - $59.89 $2.32 Million - $2.83 Million
47,300 Added 46.83%
148,300 $8.88 Million
Q4 2020

Feb 16, 2021

SELL
$42.19 - $51.5 $1.93 Million - $2.36 Million
-45,800 Reduced 31.2%
101,000 $5.04 Million
Q3 2020

Nov 16, 2020

SELL
$35.33 - $51.04 $1.8 Million - $2.6 Million
-50,900 Reduced 25.75%
146,800 $7.49 Million
Q2 2020

Aug 14, 2020

BUY
$22.91 - $39.83 $4.53 Million - $7.87 Million
197,700 New
197,700 $6.94 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.